An official communication from the executive director of the Medical Cannabis Regulatory Board (JRCM), Marjorie Tolentino Rivera, reveals that the entity is considering the possibility of setting fixed prices for medical cannabis. This has raised concerns among members of the industry, who view the initiative as a potential undue market intervention and a distraction from the real issues affecting the sector.